Skip to main content
OpenTrials
Completed

NCT Number: NCT05528731

Perception of Female Hormonal Contraception by the Main Prescribers

The recommendations for contraception, after researching contraindications to certain methods, are to offer clear and honest information to allow the patient to make an informed choice, adapted to her lifestyle. The best contraception is the one chosen by the patient. The choice of contraception illustrates the difficulty of assessing the benefit-risk balance in the context of functional and preventive treatment.

Taking into account this imbalance between patient beliefs and medical advice is an essential step in improving the provision of gynecological care.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Service d'Assistance Médicale à la Procréation - CHU de Strasbourg - France

Strasbourg, 67091, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Any health care professional in general medicine, gynecology and midwifery
  • graduate or in progress
  • in practice (any practice modality in metropolitan France)
  • agreeing to participate in the survey by completing the questionnaire anonymously, after having read the information and non-objection notice attached to the questionnaire.

Exclusion criteria

  • Any other health profession

Inclusion criteria

  • Any health care professional in general medicine, gynecology and midwifery

Treatment and study plan

Primary outcomes

  1. Study of the perception of risks and management of adverse effects of hormonal contraception among prescribers

    Time frame: 5 months after interviews with prescribers

Sponsors and collaborators

Lead sponsor

University Hospital, Strasbourg, France

Other

Registry information

Acronym: CHF

Important dates

Study start
2022
Primary completion
2022
Study completion
2023
First posted
Sep 6, 2022
Registry last updated
Dec 13, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.